April 9, 2025
More effective combinations of targeted therapies, strategies to minimize side effects, the use of subcutaneous rather than intravenous immunotherapies, and artificial intelligence (AI) tools to better […]
April 7, 2025
A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do not […]
April 7, 2025
TOPLINE: A new analysis found that the incidence of interval breast cancers diagnosed in screened patients has increased over an almost 30-year period, but the proportion […]
April 7, 2025
TOPLINE: The overall incidence of colorectal cancer (CRC) in the United Kingdom plateaued at 67.4 per 100,000 person-years from 2000 to 2021, with slight improvements observed […]
April 4, 2025
When Mateo Mejia Saldarriaga, MD, first started seeing multiple myeloma (MM) patients as a medical student in his native Colombia 10 years ago, he was intrigued […]
April 3, 2025
Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients with unresectable, locally advanced, stage III non–small cell lung cancer […]
April 3, 2025
Durvalumab consolidation therapy reduced the rate of extrathoracic metastases vs placebo and prolonged the time to progression or death due to any metastases in patients with […]
April 2, 2025
TOPLINE: Compared with chemotherapy, immune checkpoint inhibitors (ICIs) were associated with improved overall survival in patients with microsatellite instable metastatic colorectal cancer (CRC), particularly when used […]
April 1, 2025
TOPLINE: Low-dose CT screening in a high-risk population detected lung cancer in 2.0% of participants, with nearly 80% of cases diagnosed at stage I or II. […]